Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Authors
Keywords
Biomarkers, Hepatocellular carcinoma, MicroRNAs, Monocytes, Neutrophils, Lymphocytes, Cancer treatment, Antifreeze proteins
Journal
PLoS One
Volume 15, Issue 3, Pages e0222259
Publisher
Public Library of Science (PLoS)
Online
2020-03-26
DOI
10.1371/journal.pone.0222259
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Transforming Growth Factor Beta Receptor I Kinase Inhibitor Galunisertib ( LY 2157299) in Advanced Hepatocellular Carcinoma
- (2019) Sandrine Faivre et al. LIVER INTERNATIONAL
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?
- (2016) Hyun Young Woo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
- (2016) Masatoshi Kudo Liver Cancer
- Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma
- (2015) Yang Wen et al. INTERNATIONAL JOURNAL OF CANCER
- High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma
- (2014) Wen-yao Wang et al. Diagnostic Pathology
- Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis
- (2014) Jiang Chen et al. PLoS One
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Predictive Biomarkers of Antiangiogenic Therapy for Advanced Hepatocellular Carcinoma: Where Are We?
- (2013) Yu-Yun Shao et al. Liver Cancer
- Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses
- (2012) Jean-Luc Raoul et al. JOURNAL OF HEPATOLOGY
- Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
- (2012) Nicola Personeni et al. JOURNAL OF HEPATOLOGY
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
- (2012) Angela M Liu et al. BMJ Open
- Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study
- (2010) Emilia Fransvea et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Targeting transforming growth factor (TGF)-βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma
- (2009) Emilia Fransvea et al. HEPATOLOGY
- Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
- (2008) Emilia Fransvea et al. HEPATOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now